Literature DB >> 22586167

B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE.

Shigeru Iwata, Kazuyoshi Saito, Mikiko Tokunaga, Yoshiya Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22586167     DOI: 10.1136/annrheumdis-2012-201317

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

Review 1.  Immunomodulatory drugs: oral and systemic adverse effects.

Authors:  Antonio Bascones-Martinez; Riikka Mattila; Rafael Gomez-Font; Jukka H Meurman
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.